Recent Finacing
Recent Raise
Phost'in Therapeutics develops molecules targeting abnormal glycosylation, advancing an oncology-derived lead in preclinical fibrosis models and planning a Phase I safety trial for chronic non-cancer fibrosis.
This company doesn't have industry or investor information available.
Total Raised
Funding round
